Sophia Eilat-Tsanani:Uptake of pneumococcal vaccination in older people in northern Israel (Prev Med Rep . )
Date
![syringe pixabay](/sites/medicine/files/images/wnew/syringe-1712511_1280%20pixabay_4.png)
The 23-valent pneumococcal vaccine is recommended for people aged 65 years and over, to prevent pneumonia, a leading cause of infectious morbidity in older people. This study assessed pneumococcal vaccination in people aged 65-74 years living in northern Israel who were eligible for the pneumococcal vaccine since introduction free of charge.
Last Updated Date : 03/01/2022